Rmr Wealth Builders Eli Lilly & CO Transaction History

Rmr Wealth Builders

$1.08 Billion
Q2 2025

A detailed history of Rmr Wealth Builders transactions in Eli Lilly & CO stock. As of the latest transaction made, Rmr Wealth Builders holds 5,194 shares of LLY stock, worth $4.36 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

5,194

Previous 4,917 5.63%

Holding current value

$4.36 Million

Previous $4.06 Million 0.3%

% of portfolio

0.37%

Previous 0.43%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 08, 2025	BUY	$713.71 - $898.95 $197,697 - $249,009	277 Added 5.63%	5,194 $4.05 Million
Q1 2025 Apr 16, 2025	BUY	$725.72 - $929.72 $167,641 - $214,765	231 Added 4.93%	4,917 $4.06 Million
Q4 2024 Jan 10, 2025	BUY	$727.2 - $932.06 $77,810 - $99,730	107 Added 2.34%	4,686 $3.62 Million
Q3 2024 Oct 21, 2024	BUY	$772.14 - $960.02 $87,251 - $108,482	113 Added 2.53%	4,579 $4.06 Million
Q2 2024 Jul 23, 2024	BUY	$724.87 - $909.04 $213,111 - $267,257	294 Added 7.05%	4,466 $4.04 Million
Q1 2024 Apr 15, 2024	BUY	$592.2 - $792.28 $384,930 - $514,982	650 Added 18.46%	4,172 $3.25 Million
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $191,169 - $225,363	364 Added 11.53%	3,522 $2.05 Million
Q3 2023 Oct 23, 2023	BUY	$434.7 - $599.3 $485,994 - $670,017	1,118 Added 54.8%	3,158 $1.7 Million
Q2 2023 Jul 21, 2023	BUY	$350.74 - $468.98 $304,091 - $406,605	867 Added 73.91%	2,040 $956,000
Q1 2023 Apr 11, 2023	BUY	$310.63 - $364.82 $1,553 - $1,824	5 Added 0.43%	1,173 $402,000
Q4 2022 Feb 15, 2023	BUY	$321.55 - $374.67 $375,570 - $437,614	1,168 New	1,168 $427,000
Q3 2022 Nov 08, 2022	BUY	$296.48 - $337.87 $22,532 - $25,678	76 Added 12.12%	703 $227,000
Q2 2022 Aug 02, 2022	BUY	$278.73 - $327.27 $174,763 - $205,198	627 New	627 $203,000
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $244,284 - $315,979	-1,353 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $222,324 - $287,810	1,353 New	1,353 $253,000
Q4 2020 Feb 09, 2021	SELL	$130.46 - $172.63 $182,513 - $241,509	-1,399 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $204,561 - $236,612	1,399 New	1,399 $207,000

Others Institutions Holding LLY

# of Institutions

4,452

Shares Held

782M

Call Options Held

16.5M

Put Options Held

12.2M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $798B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rmr Wealth Builders, based on Form 13F filings with the SEC.

News

Stay updated on Rmr Wealth Builders with notifications on news.

Account

Rmr Wealth Builders Eli Lilly & CO Transaction History